{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:57:54Z","timestamp":1765807074111},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.cct.2012.10.003","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T21:30:55Z","timestamp":1350509455000},"page":"80-89","source":"Crossref","is-referenced-by-count":21,"title":["MAPPED study design: A 6month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging"],"prefix":"10.1016","volume":"34","author":[{"given":"N.L.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ambler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.J.","family":"Bott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gambarota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jameson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.V.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Whitcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Emberton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 9","key":"10.1016\/j.cct.2012.10.003_bb0005","first-page":"S11","article-title":"5 alpha reductase: history and clinical importance","volume":"6","author":"Marks","year":"2004","journal-title":"Rev Urol"},{"key":"10.1016\/j.cct.2012.10.003_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/pros.20188","article-title":"Differential alterations in 5a-reductase type 1 and type 2 levels during development and progression of prostate cancer","volume":"63","author":"Thomas","year":"2005","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.cct.2012.10.003_bb0015","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.juro.2006.11.095","article-title":"The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response","volume":"177","author":"Marks","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2012.10.003_bb0020","series-title":"Late breaking news","article-title":"Headline results from the REduction by Dutasteride of prostate Cancer Events (REDUCE) study","author":"Andriole G on behalf of the REDUCE study group","year":"2009"},{"key":"10.1016\/j.cct.2012.10.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)61619-X","article-title":"Dutasteride in localized prostate cancer management: the REDEEM randomized, double-blind, placebo-controlled trial","author":"Fleshner","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cct.2012.10.003_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOU.0b013e3282f19d01","article-title":"Multiparametric magnetic resonance imaging in prostate cancer: present and future","volume":"18","author":"Kurhanewicz","year":"2008","journal-title":"Curr Opin Urol"},{"issue":"6","key":"10.1016\/j.cct.2012.10.003_bb0035","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.eururo.2006.06.025","article-title":"How good is MRI at detecting and characterising cancer within the prostate?","volume":"50","author":"Kirkham","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.cct.2012.10.003_bb0040","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"issue":"8 Pt 2","key":"10.1016\/j.cct.2012.10.003_bb0045","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1111\/j.1464-410X.2010.10061.x","article-title":"A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer","volume":"108","author":"Chung","year":"2011","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.cct.2012.10.003_bb0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00330-008-1153-0","article-title":"Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings","volume":"19","author":"Lemaitre","year":"2009","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.cct.2012.10.003_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/aja.2011.141","article-title":"Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics","volume":"14","author":"Ballentine Carter","year":"2012","journal-title":"Asian J Androl"},{"issue":"8 Pt2","key":"10.1016\/j.cct.2012.10.003_bb0060","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1111\/j.1464-410X.2011.10112.x","article-title":"Role of magnetic resonance imaging before initial biopsy: Comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection","volume":"108","author":"Haffner","year":"2011","journal-title":"BJU Int"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714412002303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714412002303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T22:28:57Z","timestamp":1542666537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714412002303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1551714412002303"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2012.10.003","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}